GEAR Guide to Economic Analysis and Research Online Resource n = 220 CTA

Private-led submission in health technology assessment

A global review of 220 countries, territories and areas

Health technology assessment (HTA) applies systematic, explicit methods to assess the value of a health technology across its lifecycle. Private-led submission (PLS) is the arrangement under which companies make proactive submissions to an HTA body to support appraisal and decision-making. This review maps both across 220 countries, territories and areas (CTA) — which have an identifiable HTA process, and which of those accept submissions initiated by industry.

01

Where the 220 stand

Every figure on this page is calculated live from the review dataset, so totals always reconcile to 220.

02

The global picture

Select a status or region to filter. Click any country, territory or area for its HTA body, notes and sources.

Status
World map of HTA and private-led submission statusChoropleth of 220 countries, territories and areas shaded by whether an HTA process was identified and whether private-led submission is accepted.
Small islands, city states and enclaves are drawn as points · Areas outside the review are hatched
Small territories and areas

03

How HTA and PLS status combine

Cross-tabulation · n = 220
HTA status against PLS status

Distribution by region
Status composition within each region
0% — share of CTA within region — 100%Total

Regional groupings follow the World Bank classification and are added here for navigation only; they are not part of the underlying review.

04

All 220 countries, territories and areas

Sort any column. Select a row to see review notes and full sources. The export reflects the filters currently applied.

HTA and private-led submission status for each country, territory or area, with responsible body and sources
n/d = the review could not determine this status. = no value recorded in the source. Numbered links open the sources for that entry. Click a row to open its full record above.
05

Methods, definitions and limitations

How the review was done

  1. Searched organisational reports (for example WHO documents) and published methods guidance on HTA agency websites to identify HTA status.
  2. Summarised HTA implementation status for each country, territory or area. Assumption: those without an established HTA framework are unlikely to operate a PLS system.
  3. Searched for PLS status using targeted keywords (dossier, company, private sector and related terms), interpreting original articles and grey literature where explicit guidance was absent.
  4. Concluded and mapped the availability of PLS across the target countries, territories and areas.
  5. Double-checked and verified all findings for accuracy.

Definitions

Health technology assessment (HTA)
A multidisciplinary approach that applies systematic and explicit methods to assess the value of health technologies across different stages of the technology lifecycle.
Private-led submission (PLS)
Companies make proactive submissions to HTA bodies to support appraisal and decision-making.

Status categories

    Reading this dashboard with care

    • Insufficient data is not a negative finding. For 29 countries, territories and areas the review could not establish HTA or PLS status; their HTA and PLS fields are left blank rather than recorded as “No”.
    • The empty cell in the cross-tabulation is structural. No country, territory or area is recorded as accepting PLS without an HTA process, because step 2 of the method assumes this combination does not arise.
    • Absence of evidence, not evidence of absence. “No HTA identified” means no HTA process was found in the sources searched; decision-making informed by evidence may still occur through other routes, such as essential medicines list processes.
    • Sources vary in strength. Entries rest on a mix of peer-reviewed literature, agency methods guidance, WHO country profiles and network membership lists. Follow the source links before citing any single entry.